ClinicalTrials.gov
ClinicalTrials.gov Menu

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer (PACT001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00570323
Recruitment Status : Active, not recruiting
First Posted : December 10, 2007
Last Update Posted : October 26, 2017
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Mothaffar Rimawi, Baylor Breast Care Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 2016
  Estimated Study Completion Date : December 2018
  Certification/Extension First Submitted : May 10, 2017